Publication Author: Sullivan_Sean
-
Mapping a patient-reported functional outcome measure to a utility measure for comparative effectiveness and economic evaluations in older adults with low back pain.
Rundell SD, Bresnahan BW, Heagerty PJ, Comstock BA, Friedly JL, Jarvik JG, Sullivan SD. Mapping a patient-reported functional outcome measure to a utility measure for comparative effectiveness and economic evaluations in older adults with low back pain. M
rakerr2
-
Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastases.
Seal B, Sullivan SD, Ramsey SD, Asche CV, Shermock K, Sarma S, Zagadailov EA, Farrelly E, Eaddy M. Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastases. Appl Health Econ Health Policy. 2014
rakerr2
-
Authors’ reply to Curto and Garattini: “Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers”.
Carlson JJ, Gries K, Yeung K, Sullivan SD, Garrison LP. Authors’ reply to curto and garattini: “current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers”. Appl Health Econ Health
rakerr2
-
Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer
Gold LS, Lee CI, Devine B, Nelson H, Chou R, Ramsey S, Sullivan SD. Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Oct. Available from http://www.n
rakerr2
-
The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain.
Chou R, Deyo R, Devine B, Hansen R, Sullivan S, Jarvik JG, Blazina I, Dana T, Bougatsos C, Turner J. The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain. Evid Rep Technol Assess (Full Rep). 2014 Sep;(218):1-219. doi: 10.23970/AHRQEPC
rakerr2
-
An epidemiologic model to project the impact of changes in glomerular filtration rate on quality of life and survival among persons with chronic kidney disease.
Levy AR, Perkins RM, Johnston KM, Sullivan SD, Sood VC, Agnese W, Schnitzler MA. An epidemiologic model to project the impact of changes in glomerular filtration rate on quality of life and survival among persons with chronic kidney disease. Int J Nephrol
rakerr2
-
A randomized trial of epidural glucocorticoid injections for spinal stenosis.
Friedly JL, Comstock BA, Turner JA, Heagerty PJ, Deyo RA, Sullivan SD, Bauer Z, Bresnahan BW, Avins AL, Nedeljkovic SS, Nerenz DR, Standaert C, Kessler L, Akuthota V, Annaswamy T, Chen A, Diehn F, Firtch W, Gerges FJ, Gilligan C, Goldberg H, Kennedy DJ, M
rakerr2
-
Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios.
Hoogendoorn M, Feenstra TL, Asukai Y, Borg S, Hansen RN, Jansson SA, Samyshkin Y, Wacker M, Briggs AH, Lloyd A, Sullivan SD, Rutten-van Mölken MP. Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical
rakerr2
-
Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers.
Carlson JJ, Gries KS, Yeung K, Sullivan SD, Garrison LP Jr. Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers. Appl Health Econ Health Policy. 2014 Jun;12(3):231-8. doi: 10
rakerr2
-
Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens.
Hansen RN, Ramsey SD, Lalla D, Masaquel A, Kamath T, Brammer M, Hurvitz SA, Sullivan SD. Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens. Springerplus. 2014 May 21;3:259. doi: 10.1186/2193-18
rakerr2